NEW: OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion Spoke with CEO Daniel Nadler after the company's latest funding round.. talked meteoric growth in app usage, healthcare competition with OpenAI and Anthropic, IPO window and more. More details and full @CNBC interview here⬇️ https://www.cnbc.com/2026/01/21/openevidence-chatgpt-for-doctors-doubles-valuation-to-12-billion.html(Kate Rooney)